A citation-based method for searching scientific literature

J W Goodwin, J Crowley, H J Eyre, B Stafford, K A Jaeckle, J J Townsend. J Neurooncol 1993
Times Cited: 98







List of co-cited articles
827 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
S M Grunberg, M H Weiss, I M Spitz, J Ahmadi, A Sadun, C A Russell, L Lucci, L L Stevenson. J Neurosurg 1991
275
48

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
U M Schrell, M G Rittig, M Anders, U H Koch, R Marschalek, F Kiesewetter, R Fahlbusch. J Neurosurg 1997
132
40

Temozolomide for treatment-resistant recurrent meningioma.
Marc C Chamberlain, Denice D Tsao-Wei, Susan Groshen. Neurology 2004
101
40

The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B.
S E Kaba, F DeMonte, J M Bruner, A P Kyritsis, K A Jaeckle, V Levin, W K Yung. Neurosurgery 1997
95
40

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Warren P Mason, Fred Gentili, David R Macdonald, Subramanian Hariharan, Charlene R Cruz, Lauren E Abrey. J Neurosurg 2002
104
37

Salvage chemotherapy with CPT-11 for recurrent meningioma.
Marc C Chamberlain, Denice D Tsao-Wei, Susan Groshen. J Neurooncol 2006
64
56

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
Marc C Chamberlain, Michael J Glantz, Camilo E Fadul. Neurology 2007
121
36

Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.
Steven M Grunberg, Martin H Weiss, Christy A Russell, Irving M Spitz, Jamshid Ahmadi, Alfredo Sadun, Regine Sitruk-Ware. Cancer Invest 2006
108
33

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Andrew D Norden, Jeffrey J Raizer, Lauren E Abrey, Kathleen R Lamborn, Andrew B Lassman, Susan M Chang, W K Alfred Yung, Mark R Gilbert, Howard A Fine, Minesh Mehta,[...]. J Neurooncol 2010
108
33




Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, Andrew D Norden, Timothy F Cloughesy, Lauren E Abrey, Howard A Fine, Susan M Chang, H Ian Robins, Karen Fink,[...]. Neuro Oncol 2009
90
31


Mifepristone (RU 486) treatment of meningiomas.
S W Lamberts, H L Tanghe, C J Avezaat, R Braakman, R Wijngaarde, J W Koper, H de Jong. J Neurol Neurosurg Psychiatry 1992
111
26


Non-resectable slow-growing meningiomas treated by hydroxyurea.
David Loven, Ruth Hardoff, Zvi Bar Sever, Adam P Steinmetz, Michael Gornish, Zvi H Rappaport, Eyal Fenig, Zvi Ram, Aaron Sulkes. J Neurooncol 2004
59
38

Progesterone and estrogen receptors in meningiomas: prognostic considerations.
D W Hsu, J T Efird, E T Hedley-Whyte. J Neurosurg 1997
237
22

Treatment of high risk or recurrent meningiomas with hydroxyurea.
Mark A Rosenthal, David L Ashley, Lawrence Cher. J Clin Neurosci 2002
49
44

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
Emil Lou, Ashley L Sumrall, Scott Turner, Katherine B Peters, Annick Desjardins, James J Vredenburgh, Roger E McLendon, James E Herndon, Frances McSherry, Julie Norfleet,[...]. J Neurooncol 2012
114
22

Antiestrogenic therapy of meningiomas--a pilot study.
T M Markwalder, R W Seiler, D T Zava. Surg Neurol 1985
46
45

Hydroxyurea chemotherapy for unresectable or residual meningioma.
H B Newton, M A Slivka, C Stevens. J Neurooncol 2000
75
28

Atypical and anaplastic meningiomas treated with bevacizumab.
Lakshmi Nayak, Fabio M Iwamoto, Jeremy D Rudnick, Andrew D Norden, Eudocia Quant Lee, Jan Drappatz, Antonio Omuro, Thomas J Kaley. J Neurooncol 2012
110
21

Chemotherapy for meningiomas.
A P Kyritsis. J Neurooncol 1996
61
32

Meningioma: analysis of recurrence and progression following neurosurgical resection.
R O Mirimanoff, D E Dosoretz, R M Linggood, R G Ojemann, R L Martuza. J Neurosurg 1985
760
19


Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography.
C Muhr, O Gudjonsson, A Lilja, M Hartman, Z J Zhang, B Långström. Clin Cancer Res 2001
43
41

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.
David A Reardon, Andrew D Norden, Annick Desjardins, James J Vredenburgh, James E Herndon, April Coan, John H Sampson, Sridharan Gururangan, Katherine B Peters, Roger E McLendon,[...]. J Neurooncol 2012
49
36

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
143
18

Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
Barbara M Hahn, Ulrich M H Schrell, Rolf Sauer, Rudolf Fahlbusch, Oliver Ganslandt, Gerhard G Grabenbauer. J Neurooncol 2005
40
42






Medical therapies for meningiomas.
Patrick Y Wen, Eudocia Quant, Jan Drappatz, Rameen Beroukhim, Andrew D Norden. J Neurooncol 2010
102
16


Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.
Derek R Johnson, David W Kimmel, Patrick A Burch, Terrence L Cascino, Caterina Giannini, Wenting Wu, Jan C Buckner. Neuro Oncol 2011
52
30



Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor.
T Todo, E F Adams, R Fahlbusch, T Dingermann, H Werner. J Neurosurg 1996
57
24

Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products.
M Maxwell, T Galanopoulos, E T Hedley-Whyte, P M Black, H N Antoniades. Int J Cancer 1990
116
14



Meningioma pathology, genetics, and biology.
Katrin Lamszus. J Neuropathol Exp Neurol 2004
123
14

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.
Jeffrey J Raizer, Sean A Grimm, Alfred Rademaker, James P Chandler, Kenji Muro, Irene Helenowski, Laurie Rice, Katie McCarthy, Sandra K Johnston, Maciej M Mrugala,[...]. J Neurooncol 2014
61
22

Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
Yongli Ji, Cathryn Rankin, Steven Grunberg, Andy E Sherrod, Jamshid Ahmadi, Jeannette J Townsend, Lynn G Feun, Ruth K Fredericks, Christy A Russell, Fairooz F Kabbinavar,[...]. J Clin Oncol 2015
65
21

Tumors of the brain and nervous system after radiotherapy in childhood.
E Ron, B Modan, J D Boice, E Alfandary, M Stovall, A Chetrit, L Katz. N Engl J Med 1988
666
13

Expression and activation of epidermal growth factor receptors in meningiomas.
R S Carroll, P M Black, J Zhang, M Kirsch, I Percec, N Lau, A Guha. J Neurosurg 1997
65
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.